• OPEN AN ACCOUNT
Indian Indices
Sensex
77,654.60 888.68
( 1.16%)
Global Indices
Nasdaq
52,776.51 545.43
(1.04%)
Dow Jones
7,451.65 17.47
(0.23%)
Hang Seng
61,006.88 -1,358.04
(-2.18%)
Nikkei 225
10,896.96 25.94
(0.24%)
Forex
USD-INR
95.97 -0.70
(-0.72%)
EUR-INR
109.29 -0.89
(-0.81%)
GBP-INR
127.84 -1.20
(-0.93%)
JPY-INR
0.59 0.00
(-0.81%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
629.4942217
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
73.99
196989.63
EPS(TTM)
Face Value()
Div & Yield %
100.29
2
0.4
 

Centuple Global reports standalone net loss of Rs 0.48 crore in the March 2026 quarter
Jun 01,2026
Net loss of Centuple Global reported to Rs 0.48 crore in the quarter ended March 2026 as against net profit of Rs 0.06 crore during the previous quarter ended March 2025. Sales rose 111664.00% to Rs 279.41 crore in the quarter ended March 2026 as against Rs 0.25 crore during the previous quarter ended March 2025.

For the full year,net profit rose 4933.33% to Rs 1.51 crore in the year ended March 2026 as against Rs 0.03 crore during the previous year ended March 2025. Sales rose 114662.00% to Rs 573.81 crore in the year ended March 2026 as against Rs 0.50 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales279.410.25 111664 573.810.50 114662
OPM %-0.1432.00 -0.4012.00 -
PBDT-0.380.08 PL 2.290.06 3717
PBT-0.380.08 PL 2.290.05 4480
NP-0.480.06 PL 1.510.03 4933